[General therapy of type C chronic hepatitis: efficacy and limitation of hepatoprotective agents].
Shiraki
Katsuya
K
Takei
Yoshiyuki
Y
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002756:Cholagogues and Choleretics / Q000627:therapeutic use*; D006034:Glycyrrhetinic Acid / Q000627:therapeutic use; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D002756:Cholagogues and Choleretics; D014580:Ursodeoxycholic Acid; D006034:Glycyrrhetinic Acid